Both, GMCSF- and FLT3L-BMDCs responded to mOVA2 infection with type I IFN activation signatures, e.g. induction of p-STAT1(Y701), STAT1, TAP1 and ISG15 (Fig. 3a, b). The gene discussed is TAP1; the disease is infection.